ID   DoGKiT
AC   CVCL_2023
SY   DOGKIT
DR   BioSample; SAMN03473509
DR   DSMZ; ACC-629
DR   DSMZCellDive; ACC-629
DR   Wikidata; Q54831344
RX   PubMed=17562080;
RX   PubMed=17622530;
RX   PubMed=26727417;
CC   Virology: EBV-negative.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-629
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 15,16
ST   Penta E: 7,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
RX   PubMed=17562080; DOI=10.1007/s00432-007-0241-x;
RA   Bracht K., Kiefer T., Dolken G., Bednarski P.J.;
RT   "Characterization of three B-cell lymphoma cell lines from
RT   chemotherapy resistant patients with respect to in vitro sensitivity
RT   to 21 antitumor agents, ABC-transporter expression and cellular redox
RT   status.";
RL   J. Cancer Res. Clin. Oncol. 133:957-967(2007).
//
RX   PubMed=17622530; DOI=10.1007/s00277-007-0313-7;
RA   Kiefer T., Schuler F., Knopp A., Wimmer M., Hirt C., Schaefer H.-E.,
RA   Dolken G.;
RT   "A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18)
RT   translocations.";
RL   Ann. Hematol. 86:821-830(2007).
//
RX   PubMed=26727417; DOI=10.3109/10428194.2015.1108414;
RA   Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for double-hit
RT   B-cell lymphomas.";
RL   Leuk. Lymphoma 57:1015-1020(2016).
//